C
RPRX icon

Covestor’s Royalty Pharma RPRX Stock Holding History

Covestor’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76K Sell
1,359
-681
-33% -$35.4K 0.04% 532
2026
Q1 		$98K Sell
2,040
-1,900
-48% -$83.2K 0.07% 299
2025
Q4 		$152K Buy
3,940
+162
+4% +$6.18K 0.08% 334
2025
Q3 		$133K Sell
3,778
-14
-0.4% -$507 0.07% 404
2025
Q2 		$137K Sell
3,792
-3,665
-49% -$121K 0.08% 374
2025
Q1 		$232K Sell
7,457
-542
-7% -$17.2K 0.15% 111
2024
Q4 		$204K Sell
7,999
-327
-4% -$8.67K 0.13% 168
2024
Q3 		$236K Sell
8,326
-1,331
-14% -$36.9K 0.15% 126
2024
Q2 		$255K Buy
9,657
+941
+11% +$26.1K 0.17% 98
2024
Q1 		$265K Buy
8,716
+6,139
+238% +$181K 0.17% 75
2023
Q4 		$72K Buy
2,577
+1,348
+110% +$37K 0.05% 689
2023
Q3 		$33K Buy
1,229
+221
+22% +$6.56K 0.02% 943
2023
Q2 		$31K Sell
1,008
-1,716
-63% -$58.1K 0.02% 979
2023
Q1 		$98K Buy
2,724
+758
+39% +$28.1K 0.09% 383
2022
Q4 		$78K Buy
1,966
+67
+4% +$2.8K 0.06% 531
2022
Q3 		$76K Buy
1,899
+1,892
+27,029% +$80.8K 0.07% 509
2022
Q2 		$0 Sell
7
-6
-46% -$246 ﹤0.01% 2293
2022
Q1 		$1K Sell
13
-1
-7% -$39 ﹤0.01% 1931
2021
Q4 		$1K Buy
+14
New +$544 ﹤0.01% 1906

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's RPRX Position: Q2 2026 in Review

Covestor reduced its Royalty Pharma (RPRX) stake by 33% in Q2 2026, selling an estimated $35.4K and leaving 1,359 shares worth $76K. The position accounts for 0.04% of the portfolio, ranked #532.

Covestor first reported a position in RPRX in Q4 2021 and has held it in 19 quarters since. The position peaked at $265K in Q1 2024. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Covestor held 1,359 shares of Royalty Pharma worth $76K as of Q2 2026.
  • Covestor sold 681 Royalty Pharma shares in Q2 2026, an estimated $35.4K.
  • Royalty Pharma made up 0.04% of Covestor's portfolio in Q2 2026, its #532 holding.
  • Covestor first reported a position in Royalty Pharma in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Royalty Pharma position peaked at $265K in Q1 2024.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.